- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04036773
Food Pharmacy at Oregon Health & Science University (OHSU) Knight Cardiovascular Institute (KCVI)
April 18, 2022 updated by: Tracy Severson, Oregon Health and Science University
The Impact of a Fruit and Vegetable Provision Program on Cardiovascular Health
Participants in the intervention group of this study will receive weekly home deliveries of fruit & vegetables for 3 months.
The primary objective of this study is to determine if increased access to fruits and vegetables leads to sustained dietary changes, measured through changes in the Healthy Eating Index (HEI).
Secondary objectives are to determine whether increased fruit and vegetable access (increased HEI) ultimately leads to improved cardiovascular (CV) health indicators (e.g., body mass index, waist circumference, blood pressure, and levels of blood lipids and hemoglobin A1c).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health & Science University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 19 years and older
- Established patient at OHSU Center for Preventive Cardiology
- Not requiring changes to medication regimen for the 6-month study duration
- Must be eligible to register with produce delivery company (reside in Portland-metro area; have access to a computer with internet service; able to read English)
Exclusion Criteria:
- Triglycerides > 500 mg/dL
- Heavy alcohol use (> 3 drinks/day)
- Uncontrolled hypertension (BP > 140/90)
- LDL-C > 160 mg/dL
- Uncontrolled diabetes mellitus (HbA1c > 8%)
- Failure to provide informed consent
- Current pregnancy
- Healthy Eating Index (HEI) score of ≥ 80
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
|
Weekly home deliveries of approximately 15 pounds of fresh fruits & vegetables
|
|
No Intervention: Control Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intake of fruits and vegetables measured by changes in Healthy Eating Index (HEI)
Time Frame: 6 months
|
The HEI uses a scoring system to evaluate a set of foods.
The scores range from 0 to 100.
An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations from the Dietary Guidelines for Americans.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in weight measured by body mass index
Time Frame: 6 months
|
weight and height will be combined to report BMI in kg/m^2
|
6 months
|
|
Changes in waist circumference
Time Frame: 6 months
|
Waist circumference will be measured in inches using a tape measure; desirable: < 40 inches (men), < 35 inches (women)
|
6 months
|
|
Changes in total cholesterol
Time Frame: 6 months
|
measured via blood draw, desirable < 200 mg/dL
|
6 months
|
|
Changes in HDL-cholesterol
Time Frame: 6 months
|
measured via blood draw, desirable > 40 mg/dL
|
6 months
|
|
Changes in LDL-cholesterol
Time Frame: 6 months
|
measured via blood draw, desirable < 100 mg/dL
|
6 months
|
|
Changes in triglycerides
Time Frame: 6 months
|
measured via blood draw, desirable < 150 mg/dL
|
6 months
|
|
Changes in blood pressure
Time Frame: 6 months
|
Measured by medical assistant in clinic, desirable < 120/80 mmHg
|
6 months
|
|
Changes in blood glucose
Time Frame: 6 months
|
measured via blood draw, desirable range is 60-99 mg/dL
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tracy Severson, RDN, Oregon Health and Science University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 14, 2019
Primary Completion (Actual)
December 15, 2020
Study Completion (Actual)
December 15, 2020
Study Registration Dates
First Submitted
July 23, 2019
First Submitted That Met QC Criteria
July 25, 2019
First Posted (Actual)
July 30, 2019
Study Record Updates
Last Update Posted (Actual)
April 20, 2022
Last Update Submitted That Met QC Criteria
April 18, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19413
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperlipidemias
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.CompletedHyperlipidemias, Hypercholesterolemia, Mixed DyslipidemiaChina
-
Shandong Suncadia Medicine Co., Ltd.Not yet recruiting
-
Shandong Suncadia Medicine Co., Ltd.RecruitingHyperlipidemiasChina
-
Riphah International UniversityCompleted
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Salubris (Chengdu) Biotechnology Co., Ltd.CompletedHyperlipidemiasChina
-
Riphah International UniversityCompleted
-
Beijing Suncadia Pharmaceuticals Co., LtdNot yet recruiting
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingHypercholesterolemiaItaly
-
Shandong Suncadia Medicine Co., Ltd.Recruiting
-
Merck Sharp & Dohme LLCRecruitingHyperlipidemiaUnited States, Canada, Spain, Brazil, Hungary, Australia, Argentina, Israel, New Zealand, United Kingdom, Turkey (Türkiye)
Clinical Trials on Fruit and vegetable deliveries
-
Wholesome WaveYale-Griffin Prevention Research Center; One Community HealthCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | PovertyUnited States
-
Albert Einstein Healthcare NetworkRobert Wood Johnson FoundationCompletedFocus of the Study is on the Use of Incentives to Promote | Healthier Eating in Low-income CommunitiesUnited States
-
The University of Tennessee, KnoxvilleWithdrawn
-
Academia Sinica, TaiwanNational Taiwan University HospitalCompleted
-
Birmingham Community Healthcare NHSNSA, LLCCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
University of HawaiiUniversity of Hawaii Cancer Research CenterCompleted
-
TCI Co., Ltd.Completed
-
Stanford UniversityUniversity of California, San FranciscoCompletedCardiovascular DiseasesUnited States
-
University of ValladolidCompletedFruit and Vegetable ConsumptionSpain